Jae-Joon Jung1, Mahmoud Razavian1, Azariyas A Challa1, Lei Nie1, Reza Golestani1, Jiasheng Zhang1, Yunpeng Ye1, Kerry S Russell2, Simon P Robinson3, Donald D Heistad4, Mehran M Sadeghi5. 1. Section of Cardiovascular Medicine and Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut VA Connecticut Healthcare Systems, West Haven, Connecticut. 2. Section of Cardiovascular Medicine and Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut. 3. Lantheus Medical Imaging, North Billerica, Massachusetts; and. 4. Division of Cardiovascular Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa. 5. Section of Cardiovascular Medicine and Cardiovascular Research Center, Yale University School of Medicine, New Haven, Connecticut VA Connecticut Healthcare Systems, West Haven, Connecticut mehran.sadeghi@yale.edu.
Abstract
UNLABELLED: Calcific aortic valve disease (CAVD) is the most common cause of aortic stenosis. Matrix metalloproteinases (MMPs) are upregulated in CAVD and contribute to valvular remodeling and calcification. We investigated the feasibility and correlates of MMP-targeted molecular imaging for detection of valvular biology in CAVD. METHODS: Apolipoprotein E-deficient (apoE(-/-)) mice were fed a Western diet (WD) for 3, 6, and 9 mo (n = 108) to induce CAVD. Wild-type mice served as the control group (n = 24). The development of CAVD was tracked with CT, echocardiography, MMP-targeted small-animal SPECT imaging using (99m)Tc-RP805, and histologic analysis. RESULTS: Key features of CAVD—leaflet thickening and valvular calcification—were noted after 6 mo of WD and were more pronounced after 9 mo. These findings were associated with a significant reduction in aortic valve leaflet separation and a significant increase in transaortic valve flow velocity. On in vivo SPECT/CT images, MMP signal in the aortic valve area was significantly higher at 6 mo in WD mice than in control mice and decreased thereafter. The specificity of the signal was demonstrated by blocking, using an excess of nonlabeled precursor. Similar to MMP signal, MMP activity as determined by in situ zymography and valvular inflammation by CD68 staining were maximal at 6 mo. In vivo (99m)Tc-RP805 uptake correlated significantly with MMP activity (R(2) = 0.94, P < 0.05) and CD68 expression (R(2) = 0.98, P < 0.01) in CAVD. CONCLUSION: MMP-targeted imaging detected valvular inflammation and remodeling in a murine model of CAVD. If this ability is confirmed in humans, the technique may provide a tool for tracking the effect of emerging medical therapeutic interventions and for predicting outcome in CAVD.
UNLABELLED: Calcific aortic valve disease (CAVD) is the most common cause of aortic stenosis. Matrix metalloproteinases (MMPs) are upregulated in CAVD and contribute to valvular remodeling and calcification. We investigated the feasibility and correlates of MMP-targeted molecular imaging for detection of valvular biology in CAVD. METHODS:Apolipoprotein E-deficient (apoE(-/-)) mice were fed a Western diet (WD) for 3, 6, and 9 mo (n = 108) to induce CAVD. Wild-type mice served as the control group (n = 24). The development of CAVD was tracked with CT, echocardiography, MMP-targeted small-animal SPECT imaging using (99m)Tc-RP805, and histologic analysis. RESULTS: Key features of CAVD—leaflet thickening and valvular calcification—were noted after 6 mo of WD and were more pronounced after 9 mo. These findings were associated with a significant reduction in aortic valve leaflet separation and a significant increase in transaortic valve flow velocity. On in vivo SPECT/CT images, MMP signal in the aortic valve area was significantly higher at 6 mo in WDmice than in control mice and decreased thereafter. The specificity of the signal was demonstrated by blocking, using an excess of nonlabeled precursor. Similar to MMP signal, MMP activity as determined by in situ zymography and valvular inflammation by CD68 staining were maximal at 6 mo. In vivo (99m)Tc-RP805 uptake correlated significantly with MMP activity (R(2) = 0.94, P < 0.05) and CD68 expression (R(2) = 0.98, P < 0.01) in CAVD. CONCLUSION: MMP-targeted imaging detected valvular inflammation and remodeling in a murine model of CAVD. If this ability is confirmed in humans, the technique may provide a tool for tracking the effect of emerging medical therapeutic interventions and for predicting outcome in CAVD.
Authors: B F Stewart; D Siscovick; B K Lind; J M Gardin; J S Gottdiener; V E Smith; D W Kitzman; C M Otto Journal: J Am Coll Cardiol Date: 1997-03-01 Impact factor: 24.094
Authors: Marc Richard Dweck; Charlotte Jones; Nikhil V Joshi; Alison M Fletcher; Hamish Richardson; Audrey White; Mark Marsden; Renzo Pessotto; John C Clark; William A Wallace; Donald M Salter; Graham McKillop; Edwin J R van Beek; Nicholas A Boon; James H F Rudd; David E Newby Journal: Circulation Date: 2011-11-16 Impact factor: 29.690
Authors: Jari Satta; Jani Oiva; Tuula Salo; Heidi Eriksen; Pasi Ohtonen; Fausto Biancari; Tatu S Juvonen; Ylermi Soini Journal: Ann Thorac Surg Date: 2003-09 Impact factor: 4.330
Authors: Rama K Koppisetti; Yan G Fulcher; Alexander Jurkevich; Stephen H Prior; Jia Xu; Marc Lenoir; Michael Overduin; Steven R Van Doren Journal: Nat Commun Date: 2014-11-21 Impact factor: 14.919
Authors: Jack M Heath; Joan Fernandez Esmerats; Lucky Khambouneheuang; Sandeep Kumar; Rachel Simmons; Hanjoong Jo Journal: Cardiovasc Eng Technol Date: 2017-02-24 Impact factor: 2.495